Jean-Claude Vedovato

432 total citations
13 papers, 340 citations indexed

About

Jean-Claude Vedovato is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jean-Claude Vedovato has authored 13 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Jean-Claude Vedovato's work include Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Treatment and Pharmacology (6 papers). Jean-Claude Vedovato is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Treatment and Pharmacology (6 papers). Jean-Claude Vedovato collaborates with scholars based in France, Belgium and Spain. Jean-Claude Vedovato's co-authors include M. Mueser, Jean‐Luc Van Laethem, L. Cals, Jean‐Luc Raoul, Catherine Brézault, P. Rougier, Marc Peeters, Josep Tabernero, Julien Taı̈eb and Axel Grothey and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Jean-Claude Vedovato

12 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-Claude Vedovato France 9 296 137 75 74 66 13 340
B. Killing Germany 7 288 1.0× 141 1.0× 51 0.7× 40 0.5× 48 0.7× 9 329
Javier Sastre Valera Spain 6 288 1.0× 126 0.9× 49 0.7× 34 0.5× 100 1.5× 15 348
Anghel Adrian Udrea United States 8 261 0.9× 227 1.7× 65 0.9× 96 1.3× 41 0.6× 15 392
Wanda Honeycutt United States 9 270 0.9× 115 0.8× 33 0.4× 106 1.4× 54 0.8× 20 363
Karen Soussan-Lazard France 9 276 0.9× 108 0.8× 38 0.5× 72 1.0× 123 1.9× 11 336
Jan-Henrik Terwey United Kingdom 8 264 0.9× 104 0.8× 114 1.5× 26 0.4× 69 1.0× 20 302
See‐Chun Phan United States 11 303 1.0× 249 1.8× 45 0.6× 89 1.2× 69 1.0× 17 435
Jayne Gurtler United States 7 188 0.6× 98 0.7× 82 1.1× 68 0.9× 120 1.8× 14 332
Jara M. Baas Netherlands 11 221 0.7× 87 0.6× 75 1.0× 81 1.1× 22 0.3× 15 339
Philippe Jamme France 9 110 0.4× 149 1.1× 44 0.6× 106 1.4× 84 1.3× 22 256

Countries citing papers authored by Jean-Claude Vedovato

Since Specialization
Citations

This map shows the geographic impact of Jean-Claude Vedovato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Claude Vedovato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Claude Vedovato more than expected).

Fields of papers citing papers by Jean-Claude Vedovato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Claude Vedovato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Claude Vedovato. The network helps show where Jean-Claude Vedovato may publish in the future.

Co-authorship network of co-authors of Jean-Claude Vedovato

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Claude Vedovato. A scholar is included among the top collaborators of Jean-Claude Vedovato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Claude Vedovato. Jean-Claude Vedovato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wang, Xicheng, Yanhong Deng, Yanqiao Zhang, et al.. (2024). Encorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with BRAF V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study.. Journal of Clinical Oncology. 42(17_suppl). LBA3559–LBA3559. 1 indexed citations
2.
Cutsem, Eric Van, Julien Taı̈eb, Rona Yaeger, et al.. (2023). ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer. Journal of Clinical Oncology. 41(14). 2628–2637. 63 indexed citations
3.
Cutsem, Eric Van, Julien Taı̈eb, Rona Yaeger, et al.. (2021). O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer. Annals of Oncology. 32. S222–S222. 20 indexed citations
4.
Grothey, Axel, Josep Tabernero, Julien Taı̈eb, et al.. (2020). LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer. Annals of Oncology. 31. S242–S243. 33 indexed citations
5.
6.
Martín, Miguel, Mario Campone, Igor Bondarenko, et al.. (2018). Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane. Annals of Oncology. 29(5). 1195–1202. 12 indexed citations
7.
8.
Peeters, Marc, Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2005). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC). Ghent University Academic Bibliography (Ghent University). 17 indexed citations
9.
Delbaldo, Catherine, Jean‐Yves Pierga, Véronique Dièras, et al.. (2005). Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma. European Journal of Cancer. 41(12). 1739–1745. 71 indexed citations
10.
Rougier, P., Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2004). Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA. Journal of Clinical Oncology. 22(14_suppl). 3513–3513. 77 indexed citations
11.
Rougier, P., Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2004). Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA. Journal of Clinical Oncology. 22(14_suppl). 3513–3513. 24 indexed citations
12.
Delbaldo, Catherine, Jean‐Yves Pierga, V. Diéras, et al.. (2003). 552 Evaluation of the pharmacokinetic (PK) interactions between cetuximab and irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing advanced solid tumors. Results of a phase I study. European Journal of Cancer Supplements. 1(5). S167–S167. 6 indexed citations
13.
Raoul, Jean‐Luc, Jean‐Luc Van Laethem, Emmanuel Mitry, et al.. (2003). 289 Phase II study of cetuximab combined with FOLFIRI (bi-weekly irinotecan plus infusional 5-FU and folinic acid (FA) in patients (pts) with metastatic, Epidermal growth factor receptor (EGFR)-expressing colorectal cancer (CRC). European Journal of Cancer Supplements. 1(5). S89–S89. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Killing Breakdown of academic impact, for papers by Javier Sastre Valera Breakdown of academic impact, for papers by Anghel Adrian Udrea Breakdown of academic impact, for papers by Wanda Honeycutt Breakdown of academic impact, for papers by Karen Soussan-Lazard Breakdown of academic impact, for papers by Jan-Henrik Terwey Breakdown of academic impact, for papers by See‐Chun Phan Breakdown of academic impact, for papers by Jayne Gurtler Breakdown of academic impact, for papers by Jara M. Baas Breakdown of academic impact, for papers by Philippe Jamme
Rankless by CCL
2026